Schrodinger Earnings
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 26.60 +0.80%
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.65
Schrodinger earnings summary
Schrodinger is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.65. In its most recent report on Aug 5, 2026 (Q2 2026), SDGR posted EPS of $0.08. Revenue for the quarter was $58.9 million.
Across the last 16 reports, SDGR shares moved an average of 5.0% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
SDGR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.08 | — | -3.1% |
| May 5, 2026 | — | $-0.81 | — | -9.0% |
| Feb 25, 2026 | — | $0.45 | — | +5.6% |
| Nov 5, 2025 | — | $-0.45 | — | -0.8% |
| Aug 6, 2025 | — | $-0.59 | — | +0.9% |
| May 7, 2025 | — | $-0.82 | — | -1.4% |
| Feb 26, 2025 | — | $-0.55 | — | -5.8% |
| Nov 12, 2024 | — | $-0.52 | — | +12.4% |
| Jul 31, 2024 | — | $-0.74 | — | -6.6% |
| May 1, 2024 | — | $-0.76 | — | -4.0% |
| Feb 28, 2024 | — | $-0.41 | — | +1.3% |
| Nov 1, 2023 | — | $-0.86 | — | -3.6% |
| Aug 2, 2023 | — | $0.06 | — | -5.3% |
| May 4, 2023 | — | $1.75 | — | -5.7% |
| Feb 28, 2023 | — | $-0.39 | — | -10.3% |
| Nov 3, 2022 | — | $-0.56 | — | +5.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.